Real-World Cost Effectiveness Comparison Of Symbicort Turbuhaler And Duoresp Spiromax In UK Patients With Asthma Or Chronic Obstructive Pulmonary Disease
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1488
https://www.valueinhealthjournal.com/article/S1098-3015(17)31822-3/fulltext
Title :
Real-World Cost Effectiveness Comparison Of Symbicort Turbuhaler And Duoresp Spiromax In UK Patients With Asthma Or Chronic Obstructive Pulmonary Disease
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31822-3&doi=10.1016/j.jval.2017.08.1488
First page :
A645
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1341